Sastasundar Ventures Limited (SASTASUNDR.BO)
INR 254.0
(-3.37%)
INR 254.0
(-3.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -203.51 Million INR | 142.69% |
| 2022 | -1.08 Billion INR | -116.25% |
| 2021 | 11.22 Billion INR | -228.54% |
| 2020 | -93.56 Million INR | 69.99% |
| 2019 | -512.74 Million INR | -40.0% |
| 2018 | -332.73 Million INR | -158.11% |
| 2017 | -60.56 Million INR | 31.61% |
| 2016 | -181.19 Million INR | 28.77% |
| 2015 | -285.53 Million INR | -171.13% |
| 2014 | -82.2 Million INR | -97.92% |
| 2013 | -43.09 Million INR | -141.76% |
| 2012 | 129.25 Million INR | -54.44% |
| 2011 | 282.47 Million INR | -36.08% |
| 2010 | 441.73 Million INR | -52.05% |
| 2009 | 921.31 Million INR | 79.88% |
| 2008 | 512.17 Million INR | -22.52% |
| 2007 | 661.01 Million INR | 129.49% |
| 2006 | 288.03 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -95.02 Million INR | 1506.2% |
| 2023 Q1 | 157.46 Million INR | 150.0% |
| 2023 Q2 | 158.54 Million INR | 0.68% |
| 2023 Q4 | -18.73 Million INR | -111.38% |
| 2023 Q3 | 164.59 Million INR | 3.82% |
| 2023 FY | - INR | 142.69% |
| 2022 Q2 | -41.16 Million INR | 44.38% |
| 2022 FY | - INR | -116.25% |
| 2022 Q4 | -314.94 Million INR | -379.11% |
| 2022 Q3 | -65.73 Million INR | -59.7% |
| 2022 Q1 | -74.01 Million INR | 70.5% |
| 2021 Q3 | -100.98 Million INR | -35.69% |
| 2021 Q2 | -74.42 Million INR | -1.29% |
| 2021 Q1 | -73.47 Million INR | -48.01% |
| 2021 FY | - INR | -228.54% |
| 2021 Q4 | -250.88 Million INR | -148.45% |
| 2020 Q3 | -39.78 Million INR | -27.16% |
| 2020 Q4 | -49.64 Million INR | -24.79% |
| 2020 Q1 | -7.29 Million INR | 94.24% |
| 2020 FY | - INR | 69.99% |
| 2020 Q2 | -31.28 Million INR | -328.72% |
| 2019 Q2 | -124.29 Million INR | 12.3% |
| 2019 FY | - INR | -40.0% |
| 2019 Q4 | -126.72 Million INR | -10.46% |
| 2019 Q1 | -141.72 Million INR | 14.8% |
| 2019 Q3 | -114.71 Million INR | 7.7% |
| 2018 FY | - INR | -158.11% |
| 2018 Q4 | -166.33 Million INR | -113.18% |
| 2018 Q3 | -78.02 Million INR | -36.19% |
| 2018 Q2 | -57.29 Million INR | -16.63% |
| 2018 Q1 | -49.12 Million INR | -8.22% |
| 2017 Q3 | -6.6 Million INR | 72.1% |
| 2017 Q2 | -23.66 Million INR | 49.45% |
| 2017 Q1 | -46.81 Million INR | -22.55% |
| 2017 Q4 | -45.39 Million INR | -587.31% |
| 2017 FY | - INR | 31.61% |
| 2016 Q1 | -63.22 Million INR | 35.97% |
| 2016 FY | - INR | 28.77% |
| 2016 Q4 | -38.2 Million INR | 26.32% |
| 2016 Q3 | -51.84 Million INR | -78.87% |
| 2016 Q2 | -28.98 Million INR | 54.15% |
| 2015 Q3 | -77.04 Million INR | -11.52% |
| 2015 Q1 | -40.68 Million INR | 32.8% |
| 2015 Q2 | -69.08 Million INR | -69.82% |
| 2015 Q4 | -98.73 Million INR | -28.15% |
| 2015 FY | - INR | -171.13% |
| 2014 Q4 | -60.53 Million INR | -716.73% |
| 2014 Q3 | -7.41 Million INR | 27.4% |
| 2014 Q1 | -7.11 Million INR | 90.45% |
| 2014 Q2 | -10.21 Million INR | -43.48% |
| 2014 FY | - INR | -97.92% |
| 2013 Q2 | 83 Thousand INR | 101.02% |
| 2013 FY | - INR | -141.76% |
| 2013 Q3 | -8.98 Million INR | -10922.89% |
| 2013 Q1 | -8.15 Million INR | 97.85% |
| 2013 Q4 | -74.49 Million INR | -729.34% |
| 2012 Q3 | 72.76 Million INR | 18.8% |
| 2012 Q2 | 61.25 Million INR | 16.51% |
| 2012 Q1 | 52.57 Million INR | 0.0% |
| 2012 FY | - INR | -54.44% |
| 2012 Q4 | -378.91 Million INR | -620.75% |
| 2011 Q1 | - INR | 0.0% |
| 2011 FY | - INR | -36.08% |
| 2011 Q2 | - INR | 0.0% |
| 2010 FY | - INR | -52.05% |
| 2009 FY | - INR | 79.88% |
| 2008 FY | - INR | -22.52% |
| 2007 FY | - INR | 129.49% |
| 2006 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phaarmasia Limited | -1.58 Million INR | -12764.286% |
| ANG Lifesciences India Limited | 90.66 Million INR | 324.474% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 346.339% |
| Bacil Pharma Limited | -569.32 Thousand INR | -35646.68% |
| BDH Industries Limited | 124.27 Million INR | 263.763% |
| Beryl Drugs Limited | 26.63 Million INR | 863.966% |
| Cian Healthcare Limited | 122.56 Million INR | 266.042% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 1332.068% |
| Colinz Laboratories Limited | 5.42 Million INR | 3849.318% |
| Concord Drugs Limited | 40.52 Million INR | 602.253% |
| Deccan Health Care Limited | 37.5 Million INR | 642.615% |
| DECIPHER LABS LIMITED | -2.72 Million INR | -7382.096% |
| Denis Chem Lab Limited | 224.84 Million INR | 190.511% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 1381.81% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 124.49% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | 31960.936% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 1811.92% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 153.859% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 1856.846% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 133.339% |
| Makers Laboratories Limited | 25.81 Million INR | 888.443% |
| Medi-Caps Limited | 4.77 Million INR | 4365.626% |
| MedPlus Health Services Limited | 3.94 Billion INR | 105.164% |
| Panchsheel Organics Limited | 189.36 Million INR | 207.47% |
| Parmax Pharma Limited | 22.93 Million INR | 987.251% |
| Parnax Lab Limited | 243.59 Million INR | 183.544% |
| Patidar Buildcon Limited | -5.52 Million INR | -3582.827% |
| PRAVEG LIMITED | 321.43 Million INR | 163.314% |
| Mercury Laboratories Limited | 101.18 Million INR | 301.124% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 332.367% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -50026.355% |
| Smruthi Organics Limited | 120.31 Million INR | 269.154% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 554.23% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 180.069% |
| Sunil Healthcare Limited | 93.07 Million INR | 318.645% |
| Syschem (India) Limited | 70.4 Million INR | 389.077% |
| Trident Lifeline Limited | 102.69 Million INR | 298.176% |
| Transchem Limited | 56.61 Million INR | 459.494% |
| Trinity League India Limited | -26.25 Million INR | -675.199% |
| Tyche Industries Limited | 128.2 Million INR | 258.738% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 152.598% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | -528.534% |
| Vivanza Biosciences Limited | 11.2 Million INR | 1916.432% |
| Zenith Healthcare Limited | 4.98 Million INR | 4180.052% |
| Zenlabs Ethica Limited | 27.09 Million INR | 851.081% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 328.641% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 341.627% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | -34.73% |
| Roopa Industries Limited | 55.7 Million INR | 465.367% |
| PANJON LTD. | 4.08 Million INR | 5077.085% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | -65.079% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | -968.198% |
| Anuh Pharma Limited | 878.5 Million INR | 123.166% |
| Crestchem Limited | 30.33 Million INR | 770.9% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | -1781.244% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 848.402% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 152.32% |
| Trimurthi Limited | -2.47 Million INR | -8111.103% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 193.961% |
| Norris Medicines Limited | -1.78 Million INR | -11306.752% |
| Veerhealth Care Limited | 15.99 Million INR | 1372.354% |
| Lactose (India) Limited | 201.22 Million INR | 201.139% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | -111.616% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 219.312% |
| Gennex Laboratories Limited | 219.35 Million INR | 192.777% |
| Godavari Drugs Limited | 134.62 Million INR | 251.17% |
| Zenotech Laboratories Limited | 172.64 Million INR | 217.879% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 145.349% |
| Bharat Parenterals Limited | 265.74 Million INR | 176.583% |
| Coral Laboratories Limited | 227.07 Million INR | 189.623% |
| Evoq Remedies Limited | 6.18 Million INR | 3388.847% |
| Kerala Ayurveda Limited | 70.78 Million INR | 387.501% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | -2273.883% |
| Natural Capsules Limited | 219.9 Million INR | 192.548% |
| Auro Laboratories Limited | 121.73 Million INR | 267.176% |